Autolus Therapeutics (AUTL) Revenue (2022 - 2026)
Autolus Therapeutics (AUTL) revenue from Sep 30, 2022 to Mar 31, 2026. The TTM Autolus Therapeutics (AUTL) revenue is $93M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Autolus Therapeutics (AUTL) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +927.97% |
Annual Revenue change of Autolus Therapeutics (AUTL)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $26M | -65.22% |
| 2025 | $75M | +644.96% |
| 2024 | $10M | +495.29% |
| 2023 | $1.70M | N/A |
| 2022 | $0 | N/A |
| 2021 | $0 | N/A |
| 2020 | $0 | -100.00% |
| 2019 | $2.91M | +870.00% |
| 2018 | $300K | +30.43% |
| 2017 | $230K | -80.99% |
| 2016 | $1.21M | N/A |